Y
Yoshiharu Iwabuchi
Researcher at Tohoku University
Publications - 256
Citations - 5864
Yoshiharu Iwabuchi is an academic researcher from Tohoku University. The author has contributed to research in topics: Catalysis & Alcohol oxidation. The author has an hindex of 39, co-authored 244 publications receiving 5296 citations. Previous affiliations of Yoshiharu Iwabuchi include Kanagawa University & Nagoya University.
Papers
More filters
Journal ArticleDOI
Chiral Amine-Catalyzed Asymmetric Baylis−Hillman Reaction: A Reliable Route to Highly Enantiomerically Enriched (α-Methylene-β-hydroxy)esters
Journal ArticleDOI
2-Azaadamantane N-Oxyl (AZADO) and 1-Me-AZADO: Highly Efficient Organocatalysts for Oxidation of Alcohols
TL;DR: Development of a stable nitroxyl radical class of catalysts, AZADO and 1-Me-AZADO, for highly efficient oxidation of alcohols is described, converting various sterically hindered alcohols to the corresponding carbonyl compounds in excellent yields.
Journal ArticleDOI
Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer
Hisatsugu Ohori,Hiroyuki Yamakoshi,Masaki Tomizawa,Masatoshi Shibuya,Yuichi Kakudo,Atsuko Takahashi,Shin Takahashi,Satoshi Kato,Takao Suzuki,Chikashi Ishioka,Yoshiharu Iwabuchi,Hiroyuki Shibata +11 more
TL;DR: A series of novel curcumin analogues were synthesized and screened for anticancer activity and exhibited neither harmful nor growth-suppressive effects on normal hepatocytes where oncogene products are not activated, suggesting that they may provide effective alternative therapies for the prevention and treatment of some human cancers.
Journal ArticleDOI
Highly efficient, organocatalytic aerobic alcohol oxidation.
TL;DR: In this paper, a simple, organocatalytic aerobic alcohol oxidation system that has a wide scope under mild conditions at ambient pressure and temperature and is weakly acidic and halogen- and transition-metal-free.
Journal ArticleDOI
Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030
Li Lin,Yan Liu,Li H,Pui-Kai Li,James R. Fuchs,Hiroyuki Shibata,Yoshiharu Iwabuchi,Jiayuh Lin +7 more
TL;DR: The results indicate that STAT3 is a novel therapeutic target in colon cancer stem cells, and inhibition of activated STAT3 in cancerstem cells by GO-Y030 may offer an effective treatment for colorectal cancer.